Abstract
Genetic Engineering & Biotechnology NewsVol. 43, No. 6 DepartmentsLifesaving Gene Therapies Will They Reach Those Who Need Them Most?Généthon maintains that the development of gene therapies for ultra-rare diseases should be a success story, not a cautionary taleFrédéric RevahFrédéric RevahFrédéric Revah, PhD, is the CEO of Généthon.Search for more papers by this authorPublished Online:5 Jun 2023https://doi.org/10.1089/gen.43.06.07AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 43Issue 6Jun 2023 Information© 2023 by GEN PublishingTo cite this article:Frédéric Revah.Lifesaving Gene Therapies Will They Reach Those Who Need Them Most?.Genetic Engineering & Biotechnology News.Jun 2023.16-17.http://doi.org/10.1089/gen.43.06.07Published in Volume: 43 Issue 6: June 5, 2023PDF download
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
